A subset analysis of diabetic patients in the SPIRIT II Clinical trial of the XIENCE V Everolimus Eluting Stent System ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
Early clinical results from Abbott's ongoing ABSORB clinical trial, the world's first study to evaluate the ...
A stent designed to dissolve after it completes its task of propping open narrowed heart arteries is being tested ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
When it comes to opening blocked carotid arteries, surgery may be less risky than stents according to a study by ...
First U.S. installations of Volcano Corp.’s s5i IVUS (intravascular ultrasound) imaging system have been completed at ...
Boston Scientific has European CE clearance to begin marketing a private-label XIENCE V everolimus-eluting coronary ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
The new Fetch Aspiration Catheter from Possis Medical, Inc. has received 510(k) clearance from the FDA. Employing ...
An FDA-appointed advisory panel to review drug-eluting stents could have detrimental effects on the $6 billion-a-year ...
Having the most up-to-date blood gas readings is critical when dealing with many patients, especially pulmonary and ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
Abbott Vascular says it will begin launching its XIENCE V stent system immediately in most European countries, focusing ...
The genesis of the Abaxis Piccolo technology began with NASA, where scientists sought to develop and manufacture a small ...
Cordis Corp. has launched the CYPHER SELECT Plus Stent, the first third-generation DES, in Western and Eastern Europe ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
Two of the six astronauts from the shuttle mission Atlantis became part of an ongoing cardiovascular study at NASA about ...
Positive six-month results of Abbott's SPIRIT II clinical trial of the XIENCE V Everolimus Eluting Coronary Stent ...
Enrollment is complete for a landmark study designed to increase clinical understanding of vulnerable plaque, the ...